The gut microbiome in Alzheimers disease: what we know and what remains to be explored
With newer GLP-1-based therapies now emerging, the field has an opportunity to test whether different drugs in this class have distinct effects on aging biology and to identify which patients may benefit most." Much larger clinical trials will be needed to confirm the results, determine how long any benefits last, and identify the most effective treatment schedules for both people with HIV and the broader population
Related: Eli Lillys Tirzepatide Shows Promise for Keeping Prediabetic Patients Diabetes-Free Participants in the trial were randomly assigned to receive either Zepbound, Wegovy or a placebo, with results measured by weight loss percentage and improvements in metabolic health markers
The compound is in Phase 3 clinical development
However, persistent or severe skin reactions, including blistering, significant swelling, or spreading rash, warrant immediate medical evaluation and may indicate contact dermatitis or allergic sensitization
